Azar Testifies on Drug Pricing, Criticizes PBMs and Rebates

Drug Industry Daily
HHS Secretary Alex Azar elaborated on the Trump administration’s blueprint to lower drug prices at a Senate HELP Committee hearing Tuesday and said it is considering — among other actions — targeting rebates, pharmacy benefit managers and Medicare negotiations.

To View This Article:


Subscribe To Drug Industry Daily